References
- Osteen KG, Yeaman GR, Bruner-Tran KL. Matrix metallo-proteinases and endometriosis. Semin Reprod Med 2003;21:155–164.
- Szamatowicz J, Laudanski P, Tomaszewska I. Matrix metallo-proteinase-9 and tissue inhibitor of matrix metalloproteinase-1: a possible role in the pathogenesis of endometriosis. Hum Reprod 2002;17: 284–288.
- Balbin M, Pendas AM, Uria JA, Jimenez MG, Freije JP, Lopez-Otin C. Expression and regulation of collagenase-3 (MMP-13) in human malignant tumors. APMIS 1999;107: 45–53.
- Hernandez-Barrantes S, Toth M, Bernardo MM, Yurkova M, Gervasi DC, Raz Y, Sang QA, Fridman R. Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-1\41\4P) to tissue inhibitor of metalloproteinase (TI1\4P)-2 regulates MT1-MMP processing and pro-MMP-2 activation. J Biol Chem 2000;275: 12080–12089.
- Chung HW, Lee JY, Moon HS, Hur SE, Park MH, Wen Y, Polan ML. Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metallopro-teinase-2 expression in ectopic and eutopic endometrium. Fertil Steril 2002;78: 787–795.
- Revised American Society for Reproductive Medicine classi-fication of endometriosis: 1996. Fertil Steril 1997;67:817–821.
- Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265–275.
- Gilabert-Estelles J, Estelles A, Gilabert J, Castello R, Espana F, Falco C, Romeu A, Chirivella M, Zorio E, Aznar J. Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis. Hum Reprod 2003;18:1516–1522.
- Wang X, Pei D. Shedding of membrane type matrix metalloproteinase 5 by a furin-type convertase: a potential mechanism for down-regulation. J Biol Chem 2001;276: 35953–35960.
- Toth M, Hernandez-Barrantes S, Osenkowski P, Bernardo MM, Gervasi DC, Shimura Y, Meroueh 0, Kotra LP, Galvez BG, Arroyo AG, et al. Complex pattern of membrane type 1 matrix metalloproteinase shedding. Regulation by autocataly-tic cell surface inactivation of active enzyme. J Biol Chem 2002;277: 26340–26350.
- Ueda M, Yamashita Y, Takehara M, Terai Y, Kumagai K, Ueki K, Kanda K, Hung YC, Ueki M. Gene expression of adhesion molecules and matrix metalloproteinases in endo-metriosis. Gynecol Endocrinol 2002;16:391–402.
- Hayashi K, Horikoshi S, Osada S, Shofuda K, Shirato I, Tomino Y. Macrophage-derived MT1-MMP and increased 1\41\4P-2 activity are associated with glomerular damage in crescentic glomerulonephritis. J Pathol 2000;191:299–305.
- Zhang J, Hampton AL, Nie G, Salamonsen LA. Progesterone inhibits activation of latent matrix metalloproteinase (1\41\4P)-2 by membrane-type 1 MMP: enzymes coordinately expressed in human endometrium. Biol Reprod 2000;62:85–94.
- Kim MH, Kitson RP, Albertsson P. Secreted and membrane-associated matrix metalloproteinases of IL-2-activated NK cells and their inhibitors. J Immunol 2000;164: 5883–5889.
- Oosterlynck DJ, Meuleman C, Waer M, Vandeputte M, Koninckx PR. The natural killer activity of peritoneal fluid lymphocytes is decreased in women with endometriosis. Fertil Steril 1992;58:290–295.
- Oosterlynck DJ, Cornillie FJ, Waer M, Vandeputte M, Koninckx PR. Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil Steril 1991;56:45–51.